This includes the tumour suppressor DLT1 (deleted in liver cancer 1) which encodes a Rho-GAP catalytic domain that negatively regulates Rho-GTPases [171] and the delayed rectifier Kv2.1 potassium channel which upon FAK interaction promotes polarized cell morphology and enhanced motility [172]. The gene discussed is PTK2; the disease is neoplasm.